
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
About the Cover
Immunohistochemistry for detecting FoxP3 (red nuclear labeling)
was used to detect and quantify regulatory T cells (Treg) in anal
carcinoma. Unexpectedly, the number of Treg cells did not affect the
prognosis. By contrast, a strong negative effect of cytotoxic T cells on
survival rates of patients with no evidence of disease was observed.
For further details, please see Grabenbauer et al. on page 3355 in this issue.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |